United StatesDexamethasone Moxifloxacin (1 mg/mL and 5 mg/mL, 1 mL intraocular injection, NDC 71384-512-0.1; lots 25MAY051 exp 06/26/2026 and 25AUG003 exp 08/07/2026), Dexamethasone Moxifloxacin Ketorolac (1 mg/mL, 0.5 mg/mL, 0.4 mg/mL single‑use intraocular injection, NDC 71384-513-01; lots 25APR001A and 25APR001B exp 04/03/2026), and Tri‑Moxi+ (triamcinolone 9 mg/0.6 mL, moxifloxacin 0.6 mg/0.6 mL single‑use intraocular injection, NDC 71384-746-06; lots 25JAN033A and 25JAN033B exp 02/12/2026) distributed nationwide by Imprimis NJOF, LLC are being recalled. They were recalled due to the presence of particulate matter described as glass-like particles.
What's being recalled
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Recalling firm: Imprimis NJOF, LLC, Ledgewood, NJ, United States.
How to identify it
Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026 Lot: 25APR001A, 25APR001B, Expires: 04/03/2026. Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.
The hazard
Presence of particulate matter - Glass like particles.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)